Get started
IMMAGE BIOTHERAPEUTICS CORPIMMAGE BIOTHERAPEUTICS CORPIMMAGE BIOTHERAPEUTICS CORP

IMMAGE BIOTHERAPEUTICS CORP

No trades
See on Supercharts
Overview
Financials
News Ideas Minds Technicals

IMMG fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The firm develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies. The company was founded by Anton Dormer and Mahesh Narayanan in 2012 and is headquartered in Bethesda, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

IMMG does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company